Stockscreener 앱 받기
5.33
0.57%
-0.03
전일 마감가:
$5.30
열려 있는:
$5.4
하루 거래량:
3,617
Relative Volume:
0.10
시가총액:
$164.66M
수익:
$15.33M
순이익/손실:
$-40.19M
주가수익비율:
-3.0419
EPS:
-1.7522
순현금흐름:
-
1주 성능:
-1.68%
1개월 성능:
-6.73%
6개월 성능:
+16.59%
1년 성능:
-43.39%
1일 변동 폭
$5.25
$5.40
1주일 범위
$4.60
$5.40
52주 변동 폭
$3.50
$10.42
Trisalus Life Sciences Inc Stock (TLSI) Company Profile
명칭
Trisalus Life Sciences Inc
전화
415 336 8917
주소
6272 WEST 91ST AVENUE, WESTMINSTER
TLSI을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
TLSI
Trisalus Life Sciences Inc
|
5.31 | 164.66M | 15.33M | -40.19M | 0 | -1.7522 |
|
ABT
Abbott Laboratories
|
125.97 | 221.85B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
97.33 | 142.24B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
370.94 | 140.07B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
93.15 | 118.98B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
69.17 | 40.31B | 5.72B | 4.17B | 259.90M | 6.97 |
Trisalus Life Sciences Inc Stock (TLSI) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-13 | 개시 | Lake Street | Buy |
| 2024-12-17 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-11-11 | 개시 | ROTH MKM | Buy |
| 2024-10-25 | 개시 | Northland Capital | Outperform |
| 2024-09-16 | 개시 | Oppenheimer | Outperform |
| 2024-05-30 | 개시 | Canaccord Genuity | Buy |
모두보기
Trisalus Life Sciences Inc 주식(TLSI)의 최신 뉴스
Can This Revolutionary Liver Cancer Treatment Double Drug Effectiveness? New Study Shows Remarkable Results - StockTitan
Short Interest in TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Expands By 75.3% - Defense World
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Receives Average Recommendation of “Buy” from Analysts - Defense World
TriSalus Life Sciences announces executive departure By Investing.com - Investing.com South Africa
TriSalus Life Sciences announces executive departure - Investing.com India
3 Stocks With Robust Growth Outlooks Insiders Are Buying - MSN
Trisalus Life Sciences CFO buys $33,900 in common stock - MSN
Dated alert on Trisalus Life Sciences entering credit agreement withdrawn -February 19, 2025 at 08:04 am EST - Marketscreener.com
TriSalus Life Sciences (NASDAQ:TLSI) Now Covered by Analysts at Lake Street Capital - MarketBeat
TriSalus Life Sciences (NASDAQ:TLSI) Coverage Initiated at Lake Street Capital - Defense World
Lake Street Initiates Coverage of TriSalus Life Sciences (TLSI) with Buy Recommendation - Nasdaq
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CFO Buys $33,900.00 in Stock - MarketBeat
Financial Comparison: TriSalus Life Sciences (NASDAQ:TLSI) versus Tenon Medical (NASDAQ:TNON) - Defense World
Tenon Medical (NASDAQ:TNON) vs. TriSalus Life Sciences (NASDAQ:TLSI) Head to Head Survey - Armenian Reporter
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CFO James Emmett Young Purchases 6,000 Shares - Armenian Reporter
CFO Makes Bold Move with Major Stock Purchase in TriSalus Life Sciences! - TipRanks
Trisalus Life Sciences CFO buys $33,900 in common stock By Investing.com - Investing.com Canada
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Given Average Rating of "Buy" by Brokerages - MarketBeat
Analysts Set TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Target Price at $11.79 - Defense World
TriSalus Life Sciences bolsters board with two new members - MSN
Insider Buying: TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CEO Purchases $25,300.90 in Stock - MarketBeat
TriSalus Life Sciences announces drawdown of $10M under credit agreement with OrbiMed - MSN
Trisalus Life Sciences Announces Key Appointments To Board Of Directors -February 03, 2025 at 05:03 pm EST - Marketscreener.com
TriSalus Life Sciences bolsters board with two new members By Investing.com - Investing.com South Africa
Healthcare Powerhouses Join TriSalus Board: Ex-Fresenius CEO and AbbVie Oncology Pioneer Unite - StockTitan
TriSalus Life Sciences, Inc. Announces Drawdown of $10 Million Tranche Under Credit Agreement with Orbimed - Marketscreener.com
Revenue Success: TriSalus Unlocks $10M Strategic Funding from Healthcare Giant OrbiMed - StockTitan
Trisalus life sciences director Sean Murphy buys $157,200 in stock - MSN
TriSalus Life Sciences expands board, appoints new directors By Investing.com - Investing.com Nigeria
TriSalus Life Sciences expands board, appoints new directors - MSN
Insider Buying: TriSalus Life Sciences, Inc. (NASDAQ:TLSI) CFO Purchases 24,000 Shares of Stock - MarketBeat
Mary T. Szela Purchases 4,826 Shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Stock - MarketBeat
TriSalus Life Sciences, Inc. (NASDAQ:TLSI) Insider Sean Murphy Buys 15,000 Shares - MarketBeat
Trisalus life sciences CFO buys shares worth $129,600 - MSN
Trisalus life sciences CEO buys $50,302 in stock - MSN
Trisalus life sciences CEO buys $50,302 in stock By Investing.com - Investing.com Australia
TriSalus Life Sciences (NASDAQ:TLSIW) Trading Down 2.9% – What’s Next? - Defense World
Trisalus Life Sciences Inc (TLSI) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Trisalus Life Sciences Inc 주식 (TLSI) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Szela Mary T | CEO AND PRESIDENT |
Jan 30 '25 |
Buy |
5.28 |
5,010 |
26,453 |
444,259 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 29 '25 |
Buy |
5.03 |
5,030 |
25,301 |
439,249 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 27 '25 |
Buy |
5.42 |
4,826 |
26,157 |
429,503 |
| Szela Mary T | CEO AND PRESIDENT |
Jan 28 '25 |
Buy |
5.12 |
4,716 |
24,146 |
434,219 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 27 '25 |
Buy |
5.31 |
15,000 |
79,650 |
182,732 |
| Murphy Sean | Chief Manuf, Strategy&Bus Dev. |
Jan 28 '25 |
Buy |
5.17 |
15,000 |
77,550 |
197,732 |
| Young James Emmett | Chief Financial Officer |
Jan 27 '25 |
Buy |
5.40 |
24,000 |
129,600 |
24,000 |
| Cox Bryan F. | CHIEF SCIENTIFIC & MANUFACT. |
Oct 05 '24 |
Sale |
4.44 |
314 |
1,394 |
86,382 |
| Frankenius Equity AB | 10% Owner |
Dec 17 '24 |
Buy |
3.97 |
62,972 |
249,999 |
6,230,748 |
| Desai Arjun JJ | Director |
Dec 10 '24 |
Sale |
3.69 |
30,000 |
110,700 |
247,127 |
1.62%
0.75%
자본화:
|
볼륨(24시간):